The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of tumor burden on treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) treated with avelumab first-line maintenance (1LM).
 
Helen Moon
Honoraria - EMD Serono (Inst); Pfizer/EMD Serono (Inst); Pfizer/NCCN (Inst)
Research Funding - Amgen (Inst); Apollomics (Inst); Arcus Biosciences (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); HUYA Bioscience International (Inst); Nektar (Inst); Pfizer (Inst); Prometheus; Revimmune (Inst); Seagen (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Aveo; Bayer; Genentech; Seagen
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis; UCB
 
Seyed Hamidreza Mahmoudpour
Employment - Merck KGaA
 
Chiemeka Ike
Employment - EMD Serono
Stock and Other Ownership Interests - Merck KGaA
 
Valerie Morris
Employment - EMD Serono
Stock and Other Ownership Interests - Merck KGaA
 
Andrew Rava
Employment - Genesis Research
 
Sonia Kim
Employment - Genesis Research
 
Haiyan Sun
Employment - Genesis Research
 
Allison Dillon
Employment - Genesis Research
 
Marty Masek
Employment - Genesis Research
 
Jocelyn Sun
Employment - Genesis Research